Healthcare
Charted: How Many People Get Depression in Their Lives?
How Many People Get Depression in Their Lives?
Depression is one of the most common mental health ailments, affecting millions of people across the world.
According to Our World in Data, one in three women and one in five men in the U.S. suffer through at least one episode of depression in their lifetime.
These charts from Our World in Data use data presented in a 2020 medical study that examine the share of people in the U.S. that have had an episode of major depression.
Measuring Depression
While most illnesses can be measured using blood tests, brain scans, and biomarkers, diagnosing depression is a bit more complex.
This study looked specifically at episodes of major depression—feeling sadness or a pronounced loss of interest for at least two weeks, along with at least five of these symptoms: fatigue, trouble concentrating, feeling excessive guilt, thoughts of death or suicide, and changes in appetite, sleep or movement.
It used data from the National Surveys on Drug Use and Health, conducted between 2005 and 2017, and focused on three aspects:
- Major episodes of depression recalled in the past year.
- Recalled past major episodes of depression.
- Previously reported, but now forgotten, major episodes of depression (recall error).
How Many People Get Depression in the U.S.?
The study found that women were more likely to have major depressive episodes than men at almost every stage of their lives.
Incidence of Depression by Age | Men | Women |
---|---|---|
18‒25 | 15.0% | 24.5% |
26‒34 | 15.1% | 26.6% |
35‒49 | 18.7% | 31.1% |
50‒64 | 19.4% | 33.2% |
65+ | 16.9% | 31.2% |
Over 24% of women and 15% of men in the U.S. under the age of 25 reported facing major episodes of depression. Some researchers have attributed this gap to hormonal changes and societal pressures.
Generally speaking, these shares build up over time, with an estimated one-third of women between the ages of 50 and 64 having recalled a major episode of depression at some point in their lives, alongside 19.4% of men.
That said, for those 65 years and older, the incidence rate actually declines. That’s because people who have depression are less likely to survive to an old age.
Towards a Future Without Depression
One problem with measuring depression is that, the older people get, the more they fail to recall incidents of depression they’ve reported in the past.
But perhaps the biggest problem is still societal. For much of history, mental illnesses including depression have been stigmatized. As a result, getting treatment or seeking therapy was often kept under wraps.
However, a growing movement to recognize depression and the emotional impact of the COVID-19 pandemic have shined a light on the importance of mental health.
The number of adults getting treatment for depression is on the rise. However, that does not necessarily mean that more people are suffering from depression, as it could instead reflect that more people are recognizing symptoms and seeking help.
This article was published as a part of Visual Capitalist's Creator Program, which features data-driven visuals from some of our favorite Creators around the world.
Healthcare
The Cost of an EpiPen in Major Markets
This visualization compares EpiPen prices around the world, with the U.S. having the highest prices by far.
The Cost of an EpiPen in Major Markets
This was originally posted on our Voronoi app. Download the app for free on iOS or Android and discover incredible data-driven charts from a variety of trusted sources.
EpiPens are auto-injectors containing epinephrine, a drug that can treat or reverse severe allergic reactions, potentially preventing death.
The global epinephrine market was valued at $1.75 billion in 2022 and is projected to reach $4.08 billion by 2030. North America represents over 60% of the market.
EpiPens, however, can be prohibitively expensive in some regions.
In this graphic, we present estimated EpiPen prices in major global markets, compiled by World Population Review and converted to U.S. dollars as of August 2023.
Why are U.S. Prices so High?
The U.S. stands out as the most expensive market for EpiPens, despite over 1 million Americans having epinephrine prescriptions. After Mylan (now part of Pfizer) acquired the rights to produce EpiPens in the U.S. in 2007, the cost of a two-pack skyrocketed to $600, up from about $60.
Country | Price (USD) |
---|---|
🇺🇸 U.S. | 300* |
🇯🇵 Japan | 98 |
🇩🇪 Germany | 85 |
🇨🇦 Canada | 80 |
🇫🇷 France | 76 |
🇦🇺 Australia | 66 |
🇬🇧 UK | 61 |
🇮🇳 India | 30 |
*Per unit cost. Commonly sold as a two-pack, meaning total cost is equal to $600
Former Mylan CEO Heather Bresch defended the price hikes to Congress, citing minimal profit margins. Mylan eventually settled with the U.S. government for a nine-figure sum.
Notably, EpiPens are available at a fraction of the cost in other developed countries like Japan, Germany, and Canada.
Making EpiPens More Affordable
Efforts to improve EpiPen affordability are underway in several U.S. states. For instance, the Colorado House approved a $60 price cap on epinephrine, now under review by the state Senate.
Similar measures in Rhode Island, Delaware, Missouri, and Vermont aim to ensure insurance coverage for epinephrine, which is not currently mandatory, although most health plans cover it.
-
Debt1 week ago
How Debt-to-GDP Ratios Have Changed Since 2000
-
Countries2 weeks ago
Population Projections: The World’s 6 Largest Countries in 2075
-
Markets2 weeks ago
The Top 10 States by Real GDP Growth in 2023
-
Demographics2 weeks ago
The Smallest Gender Wage Gaps in OECD Countries
-
United States2 weeks ago
Where U.S. Inflation Hit the Hardest in March 2024
-
Green2 weeks ago
Top Countries By Forest Growth Since 2001
-
United States2 weeks ago
Ranked: The Largest U.S. Corporations by Number of Employees
-
Maps2 weeks ago
The Largest Earthquakes in the New York Area (1970-2024)